Drug Database
N06 PSYCHOANALEPTICS
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- N06AA02 imipramine
- N06AA04 clomipramine
- N06AA06 trimipramine
- N06AA07 lofepramine
- N06AA09 amitriptyline
- N06AA10 nortriptyline
- N06AA12 doxepin
- N06AA16 dosulepin
- N06AB03 fluoxetine
- N06AB04 citalopram
- N06AB05 paroxetine
- N06AB06 sertraline
- N06AB08 fluvoxamine
- N06AB10 escitalopram
- N06AF01 isocarboxazid
- N06AF03 phenelzine
- N06AF04 tranylcypromine
- N06AG02 moclobemide
- N06AX02 tryptophan
- N06AX03 mianserin
- N06AX05 trazodone
- N06AX11 mirtazapine
- N06AX12 bupropion
- N06AX16 venlafaxine
- N06AX18 reboxetine
- N06AX21 duloxetine
- N06AX22 agomelatine
- N06AX25 Hyperici herba
- N06AX26 vortioxetine
- N06AX27 esketamine
- N06BA02 dexamfetamine
- N06BA04 methylphenidate
- N06BA07 modafinil
- N06BA09 atomoxetine
- N06BA12 lisdexamfetamine
- N06BA14 solriamfetol
- N06BC01 caffeine
- N06BX03 piracetam
- N06BX13 idebenone
- N06DA02 donepezil
- N06DA03 rivastigmine
- N06DA04 galantamine
- N06DX01 memantine
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).